SuperworthContext Therapeutics market cap CNTX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $22M
- Highest close in our data
- $308.7M
- Mar 2026
Context Therapeutics is worth $22M at the close on Oct 23, 2026, at $0.24 a share.
That is down 81% over the last year and down 62% over five years.
Its highest close in our data was $308.7M in Mar 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $22M | $22M | $308.7M | −79% |
| 2025 | $103.8M | $51.4M | $129.2M | +26% |
| 2024 | $82.5M | $15.5M | $195.7M | +357% |
| 2023 | $18M | $8.8M | $25.5M | +73% |
| 2022 | $10.4M | $10.1M | $40.6M | −64% |
| 2021 | $29.2M | $29.2M | $59M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Context Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CNTXContext Therapeutics | $22M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Context Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.